BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This advanced engineered system features glycyrrhetinic acid functionalized and docetaxel loaded liposomes. The structural matrix incorporates the highly hydrophobic taxane derivative docetaxel directly within the lipophilic hydrocarbon tail domains of its bilayer shell, whose exterior boundary is surface-modified with specific pentacyclic triterpenoid glycyrrhetinic acid targeting ligands linked via covalent lipid anchors. This precise configuration coordinates a dense target-mimetic ligand array with an optimized taxane matrix, altering the natural lateral lipid packing constraints to completely prevent physical vesicle aggregation while completely suppressing docetaxel crystallization or rapid phase separation in open laboratory testing media.
Source
Custom synthesis
Functional Group
Glycyrrhetinic acid (GA); Docetaxel
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.